Three Locations to Serve You

Clinical Research at The Allergy & Asthma Center in Georgia

Clinical Research at Allergy & Asthma Center in Georgia

DataQuest Medical Research, LLC is an independent, full time, state of the art, clinical research facility dedicated to the timely and cost effective execution of clinical trials. Studies undertaken at DataQuest include investigational and FDA approved medications for the treatment of asthma, rhinitis, and other allergic or immunologic disorders in children and adults. DataQuest was founded in 1991 by Dr. Robert Cohen, a board-certified allergist and pediatrician. In 2000, Dr. Jon Stahlman, also a board-certified allergist and pediatrician, and Certified Physician Investigator (ACRP) joined DataQuest. Located in Lawrenceville and Conyers, Georgia, the research facilities are housed in facilities contiguous with The Allergy & Asthma Center, LLC. DataQuest has earned its reputation for excellence through its professional approach to studies undertaken. Professionalism, attention to detail, and accountability characterize the DataQuest’s mission and philosophy. Whether large or small, each study benefits from the actualization of this approach, resulting in the highest quality of clinical research available. See the table below for currently enrolling studies.

What is Clinical Research? Clinical trials, or clinical research studies, are usually initiated and performed by large sponsors such as pharmaceutical companies or the U.S. government in order to help researchers find new or better treatments for various diseases or medical conditions. Private practice physicians and university based physicians will serve as “investigators” and collaborate with these sponsors to perform the studies with the help of their patients or volunteers. Study volunteers are usually randomly assigned to a group to receive a study drug or treatment. In some cases, patients may receive different doses of the study drug or even no treatment at all (placebo). All patients who volunteer for studies are educated about the requirements of the study. In addition, an “informed consent” detailing the benefits and risks of the study treatment will be presented, explained, and then signed by the study participant. All investigational studies are monitored by an independent Institutional Review Board (IRB). The IRB is responsible for protecting the rights of patients in clinical trials and protecting them from any unnecessary risks. Furthermore, all records regarding participation in a clinical trial are kept confidential.

Why participate in a Clinical Research Study? Clinical research studies provide the opportunity to receive treatments not currently available for many diseases. Clinical trials of medications help advance the knowledge about treatments for certain conditions and may help others in the future. In most cases, clinical trials provide all doctor visits, tests, and treatments free of charge. Patients participating in clinical trials receive a good deal of special attention during the trial and on follow up.

How do I know if I can participate in a Clinical Research Study? Each study will be enrolling participants of different ages and/or disease severity. Feel free to ask your doctor if you are a candidate for clinical trials. The study team will review your medical history in order to determine if you qualify.

What trials are currently ongoing and who can I contact if I am interested? Call 770-513-3921 if you are interested in participating any of our ongoing or upcoming studies or would like to be entered into our database for future studies.

Clinical Research Trials Currently Enrolling

Pediatric: Perennial Allergies

  • Introduction: We are currently conducting a research study on a new nasal spray for children with year round allergies.
  • Details: 15 week study. Exams and medications given at no cost. Compensation for time and travel.
  • Eligibility: Subject must be 4-11 years of age. Must have year round allergy symptoms.

Adult Asthma

  • Introduction: We are currently conducting a research study to help patients with moderate to severe asthma.
  • Details: Study will last 29 weeks. Exams and medications given at no cost. Compensation for time and travel.
  • Eligibility: Subject must be 12 and above. Must have been treated with oral steroids for asthma exacerbation at least once in the past year.

Pediatric Asthma

  • Introduction: We are currently conducting a research study to help children with mild to moderate asthma.
  • Details: Study will last 6 months. Exams and medications given at no cost. Compensation for time and travel.
  • Eligibility: Subject must be 4-11 years of age and have been treated with oral steroids for asthma exacerbation in the past year.

Adult Asthma

  • Introduction: We are currently conducting a research study to help patients with mild to moderate asthma.
  • Details: Study consists of 8 visits. Exams and medications given at no cost. Compensation for time and travel.
  • Eligibility: Patients must be 12 years and above. Patients must have asthma uncontrolled on non-steroidal asthma maintenance medications.

 

get-directions

get-directions

get-directions
3 Locations to Serve You.